- Report
- April 2024
- 196 Pages
Global
From €4786EUR$4,950USD£4,111GBP
- Report
- March 2018
- 205 Pages
Global
From €4036EUR$4,175USD£3,467GBP
- Report
- August 2021
- 197 Pages
Global
From €3079EUR$3,185USD£2,645GBP
€4399EUR$4,550USD£3,778GBP
- Report
- April 2023
- 110 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- January 2022
- 40 Pages
India
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
Saudi Arabia
From €2509EUR$2,595USD£2,155GBP
- Report
- March 2020
- 100 Pages
Global
From €4636EUR$4,795USD£3,982GBP
- Report
- January 2022
- 80 Pages
Africa
From €3669EUR$3,795USD£3,151GBP
- Report
- January 2022
- 40 Pages
Brazil
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
China
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
France
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
Germany
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
Ireland
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
Japan
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
Russia
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
South Korea
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
United States
From €2509EUR$2,595USD£2,155GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €2509EUR$2,595USD£2,155GBP
- Book
- September 2014
- 188 Pages
The Competent Cells market within the biotechnology industry is a specialized sector that focuses on the production of genetically modified cells. These cells are used in a variety of research and development applications, such as gene cloning, protein expression, and gene therapy. Competent cells are typically produced through a process of chemical or electrical transformation, which allows them to take up foreign DNA. This process is used to create a variety of genetically modified organisms, such as bacteria, yeast, and mammalian cells.
The Competent Cells market is an important part of the biotechnology industry, as it provides researchers with the tools they need to develop new treatments and therapies. It is also a key component of the biomanufacturing industry, as it enables the production of biopharmaceuticals and other bioproducts.
Some of the major companies in the Competent Cells market include Thermo Fisher Scientific, Merck KGaA, Promega Corporation, Agilent Technologies, and Lonza Group. Show Less Read more